专利检索 ap:("Brian K. Albrecht" OR "Steven Bellon" OR "Christiane Bode" OR "Alessandro Boezio" OR "Deborah Choquette" OR "Jean-Christophe Harmange") AND inv:"Alessandro Boezio" 第 1 页

1.

发明申请
HETEROCYCLES AS PROTEIN KINASE INHIBITORS 有权
标题翻译：杂交物作为蛋白激酶抑制剂

公开(公告)号：US20110118285A1

公开(公告)日：2011-05-19

申请号：US12994068

申请日：2009-05-22

申请人： Brian K. Albrecht , Steven Bellon , Christiane Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange

发明人： Brian K. Albrecht , Steven Bellon , Christiane Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange

IPC分类号： A61K31/519 , C07D498/02 , A61K31/437 , A61P35/00 , A61P35/04

CPC分类号： C07D471/04

摘要： Selected fused imidazole or triazole derivatives are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

摘要翻译： 选择的稠合咪唑或三唑衍生物可有效预防和治疗诸如HGF介导的疾病之类的疾病。本发明包括新颖的化合物，类似物，前药和药学上可接受的盐，用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。

2.

发明申请
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE 有权
标题翻译：熔融杂环衍生物及其使用方法

公开(公告)号：US20120148531A1

公开(公告)日：2012-06-14

申请号：US13309488

申请日：2011-12-01

申请人： Brian K. ALBRECHT , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie Springer , Markian Stec , Ning Xi , Kevin Yang

发明人： Brian K. ALBRECHT , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie Springer , Markian Stec , Ning Xi , Kevin Yang

IPC分类号： A61K31/5025 , A61K31/5377 , A61K38/21 , A61P35/00 , A61P35/04 , C07D487/04 , A61K31/538

CPC分类号： A61K31/538 , A61K31/437 , A61K31/497 , A61K31/5025 , A61K31/506 , A61K31/52 , A61K31/5377 , A61K45/06 , C07D403/12 , C07D471/04 , C07D473/34 , C07D487/04 , C07D493/04 , C07D495/04 , C07D498/04 , C07D519/00

摘要： Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

摘要翻译： 所选化合物对于预防和治疗诸如HGF介导的疾病等疾病是有效的。本发明包括新颖的化合物，类似物，前药和药学上可接受的盐，用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。

3.

发明授权
Heterocycles as protein kinase inhibitors 有权
标题翻译：杂环作为蛋白激酶抑制剂

公开(公告)号：US08691838B2

公开(公告)日：2014-04-08

申请号：US12994068

申请日：2009-05-22

申请人： Brian K. Albrecht , Steven Bellon , Christiane M. Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange

发明人： Brian K. Albrecht , Steven Bellon , Christiane M. Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange

IPC分类号： C07D519/00 , A61K31/437 , A61K31/4709 , A61P35/00

CPC分类号： C07D471/04

摘要： Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds of Formula I, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

摘要翻译： 所选化合物对于预防和治疗诸如HGF介导的疾病等疾病是有效的。本发明包括式I，其类似物，前药和药学上可接受的盐的新型化合物，用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。

4.

发明授权
Fused heterocyclic derivatives and methods of use 有权

公开(公告)号：US08217177B2

公开(公告)日：2012-07-10

申请号：US12009123

申请日：2008-01-15

申请人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange , Julia Lohman , Michele Potashman

发明人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange , Julia Lohman , Michele Potashman

IPC分类号： C07D487/04 , A61K31/4162 , A61K31/437 , A61P35/00

CPC分类号： A61K31/538 , A61K31/437 , A61K31/497 , A61K31/5025 , A61K31/506 , A61K31/52 , A61K31/5377 , A61K45/06 , C07D403/12 , C07D471/04 , C07D473/34 , C07D487/04 , C07D493/04 , C07D495/04 , C07D498/04 , C07D519/00

摘要： Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

5.

发明授权
Fused heterocyclic derivatives and methods of use 有权

公开(公告)号：US08212041B2

公开(公告)日：2012-07-03

申请号：US11879034

申请日：2007-07-13

申请人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange , Julia Lohman , Michelle Potashman

发明人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Alessandro Boezio , Deborah Choquette , Jean-Christophe Harmange , Julia Lohman , Michelle Potashman

IPC分类号： C07D487/04 , A61K31/4162 , A61K31/437 , A61P35/00

CPC分类号： C07D471/04

摘要： Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

6.

发明申请
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE 审中-公开

公开(公告)号：US20120107275A1

公开(公告)日：2012-05-03

申请号：US13323692

申请日：2011-12-12

申请人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie Springer , Markian Stec , Ning Xi , Kevin Yang

发明人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie Springer , Markian Stec , Ning Xi , Kevin Yang

IPC分类号： A61K31/5025 , A61K31/5377 , C07D498/04 , A61K31/538 , A61K38/21 , A61P31/00 , A61P3/00 , A61P5/00 , A61P37/00 , C07D487/04 , A61P35/00

CPC分类号： C07D471/04 , C07D487/04 , C07D493/04 , C07D495/04 , C07D498/04 , C07D519/00

摘要： Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

7.

发明申请
Fused heterocyclic derivatives and methods of use 有权

公开(公告)号：US20090318436A1

公开(公告)日：2009-12-24

申请号：US12287791

申请日：2008-10-14

申请人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michelle Potashman , Aaron C. Siegmund , Stephanie K. Springer , Markian Stec , Ning Xi , Kevin Yang

发明人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michelle Potashman , Aaron C. Siegmund , Stephanie K. Springer , Markian Stec , Ning Xi , Kevin Yang

IPC分类号： A61K31/5355 , C07D487/02 , A61K31/5025 , C07D413/14 , C07D471/02 , A61K31/437 , A61K31/53 , C07D498/02 , A61K31/4355 , A61P35/00

CPC分类号： C07D471/04 , C07D487/04 , C07D493/04 , C07D495/04 , C07D498/04 , C07D519/00

摘要： Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

8.

发明申请
Fused heterocyclic derivatives and methods of use 有权
标题翻译：稠合杂环衍生物和使用方法

公开(公告)号：US20090124612A1

公开(公告)日：2009-05-14

申请号：US11879034

申请日：2007-07-13

申请人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie Springer , Markian Stec , Ning Xi , Kevin Yang

发明人： Brian K. Albrecht , David Bauer , Steven Bellon , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Randall W. Hungate , Tae-Seong Kim , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie Springer , Markian Stec , Ning Xi , Kevin Yang

IPC分类号： A61K31/5377 , C07D487/04 , C07D471/04 , A61P35/04 , A61K31/437 , A61K31/5025

CPC分类号： C07D471/04

摘要： Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

摘要翻译： 所选化合物对于预防和治疗诸如HGF介导的疾病等疾病是有效的。本发明包括新颖的化合物，类似物，前药和药学上可接受的盐，用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。